These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3934126)

  • 41. [Effects of application of vancomycin in the early stage of patients with extremely severe burn].
    Zhu Z; Cao GW; Bao JJ; Hu ZH; Shen Z; Tao H; Cao B; Xu F
    Zhonghua Shao Shang Za Zhi; 2017 Apr; 33(4):206-210. PubMed ID: 28427133
    [No Abstract]   [Full Text] [Related]  

  • 42. Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin.
    Zhanel GG; Lam A; Schweizer F; Thomson K; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Noreddin AM; Karlowsky JA
    Am J Clin Dermatol; 2008; 9(4):245-54. PubMed ID: 18572975
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of efficacy and safety of teicoplanin and vancomycin in children with antineoplastic therapy-associated febrile neutropenia and gram-positive bacteremia.
    Sidi V; Roilides E; Bibashi E; Gompakis N; Tsakiri A; Koliouskas D
    J Chemother; 2000 Aug; 12(4):326-31. PubMed ID: 10949982
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro inhibition of coagulase-negative staphylococci by vancomycin/aminoglycoside-loaded cement spacers.
    Streuli JC; Exner GU; Reize CL; Merkofer C; Scott CP; Zbinden R
    Infection; 2006 Apr; 34(2):81-6. PubMed ID: 16703297
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The emergence of decreased susceptibility to vancomycin in Staphylococcus epidermidis.
    Garrett DO; Jochimsen E; Murfitt K; Hill B; McAllister S; Nelson P; Spera RV; Sall RK; Tenover FC; Johnston J; Zimmer B; Jarvis WR
    Infect Control Hosp Epidemiol; 1999 Mar; 20(3):167-70. PubMed ID: 10100541
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-level aminoglycoside-resistant enterococcus causing endocarditis successfully treated with a combination of ampicillin, imipenem and vancomycin.
    Antony SJ; Ladner J; Stratton CW; Raudales F; Dummer SJ
    Scand J Infect Dis; 1997; 29(6):628-30. PubMed ID: 9571747
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.
    Lodise TP; Patel N; Lomaestro BM; Rodvold KA; Drusano GL
    Clin Infect Dis; 2009 Aug; 49(4):507-14. PubMed ID: 19586413
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.
    Cosgrove SE; Vigliani GA; Fowler VG; Abrutyn E; Corey GR; Levine DP; Rupp ME; Chambers HF; Karchmer AW; Boucher HW
    Clin Infect Dis; 2009 Mar; 48(6):713-21. PubMed ID: 19207079
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations.
    Brauers J; Kresken M; Menke A; Orland A; Weiher H; Morrissey I
    Int J Antimicrob Agents; 2007 Mar; 29(3):322-5. PubMed ID: 17204403
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The post-antibiotic effects of linezolid against Gram-positive pathogens.
    Hosgor-Limoncu M; Ermertcan S; Tasli H; Aydemir S
    Saudi Med J; 2007 Apr; 28(4):551-4. PubMed ID: 17457476
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of Vancomycin Susceptibility Testing Results for Presumptive Categorization of Telavancin.
    Mendes RE; Farrell DJ; Flamm RK; Sader HS; Jones RN
    J Clin Microbiol; 2015 Aug; 53(8):2727-30. PubMed ID: 26019194
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glycopeptide use is associated with increased mortality in Enterococcus faecalis bacteraemia.
    Foo H; Chater M; Maley M; van Hal SJ
    J Antimicrob Chemother; 2014 Aug; 69(8):2252-7. PubMed ID: 24744303
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vancomycin therapy of oxacillin-resistant Staphylococcus aureus infections.
    Klastersky J; Coppens L; van der Auwera P; Meunier-Carpentier F
    J Antimicrob Chemother; 1983 Apr; 11(4):361-7. PubMed ID: 6552258
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Do vancomycin serum levels predict failures of vancomycin therapy or nephrotoxicity in cancer patients?
    Kralovicová K; Spanik S; Halko J; Netriova J; Studena-Mrazova M; Novotny J; Grausova S; Koren P; Krupova I; Demitrovicova A; Kukuckova E; Krcmery V
    J Chemother; 1997 Dec; 9(6):420-6. PubMed ID: 9491842
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections.
    Hermsen ED; Hanson M; Sankaranarayanan J; Stoner JA; Florescu MC; Rupp ME
    Expert Opin Drug Saf; 2010 Jan; 9(1):9-14. PubMed ID: 20021290
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ototoxicity of vancomycin and analogues.
    Brummett RE
    Otolaryngol Clin North Am; 1993 Oct; 26(5):821-8. PubMed ID: 8233491
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
    Barber KE; Smith JR; Raut A; Rybak MJ
    J Antimicrob Chemother; 2016 Jan; 71(1):152-5. PubMed ID: 26476277
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of infective endocarditis caused by methicillin-resistant Staphylococcus aureus: teicoplanin versus vancomycin in a retrospective study.
    Huang JH; Hsu RB
    Scand J Infect Dis; 2008; 40(6-7):462-7. PubMed ID: 18584532
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk of nephrotoxicity with combination vancomycin-aminoglycoside antibiotic therapy.
    Pauly DJ; Musa DM; Lestico MR; Lindstrom MJ; Hetsko CM
    Pharmacotherapy; 1990; 10(6):378-82. PubMed ID: 2287556
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nephrotoxicity of vancomycin-gentamicin therapy in pediatric patients.
    Swinney VR; Rudd CC
    J Pediatr; 1987 Mar; 110(3):497-8. PubMed ID: 3819958
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.